MedTrace Logo

Effect of Deksmedetomidine and Remifentanil in Extubation Agitation

NCT02104297 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 90

Last updated 2014-04-04

No results posted yet for this study

Summary

To compare the effect of two different agents deksmedetomidine, remifentanil and placebo, agitation and recovery condition, on nasal septum operation.

Conditions

  • Agitation

Interventions

DRUG

deksmedetomidine

deksmedetomidine infused during operation 0.2 mcg/kg/hour

DRUG

Remifentanil

Remifentanil infused during operation 0.2 mcg/kg/min

DRUG

Saline

During operation saline infused equal volüme of deksmedetomidine and remifentanil

Sponsors & Collaborators

  • Diskapi Yildirim Beyazit Education and Research Hospital

    lead OTHER_GOV

Principal Investigators

  • Reyhan Polat, MD · Yildirim Beyazit Education and Research Hospita

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2014-04-30
Primary Completion
2014-06-30
Completion
2014-06-30

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02104297 on ClinicalTrials.gov